A safety and efficacy of the cutting an ampulla of vater in ERCP
Not Applicable
- Conditions
- Biliary deseases
- Registration Number
- JPRN-UMIN000030511
- Lead Sponsor
- Aichi Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Not naiive papilla 2. Patients who need ERP for pancreatic desease 3. Patients considered ineligible for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverese events rate Early:Post ERCP pancreatitis, bleeding,perforation, et al. Late:Stenosis of the papilla, pancreatitis, cholangitis, cholecystitis
- Secondary Outcome Measures
Name Time Method Efficacy Success rate of bilialy cannulation Total procedure time